Intrinsic Value of S&P & Nasdaq Contact Us

Soligenix, Inc. SNGX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Soligenix, Inc. (SNGX) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -192.99%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -192.99%).
  • Trailing Earnings Yield -192.99% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
34/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
~
FUTURE
55/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — SNGX

Valuation Multiples
P/E (TTM)-0.5
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.11
P/S Ratio0.00
EV/EBITDA-0.3
Per Share Data
EPS (TTM)$-2.19
Book Value / Share$1.02
Revenue / Share$0.00
FCF / Share$-1.98
Yields & Fair Value
Earnings Yield-192.99%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -2.4 0.03 1.06 0.75 -
2017 -1.9 -0.08 2.16 2.51 -
2018 -1.3 0.03 1.80 2.16 -
2019 -3.0 0.11 19.28 8.74 -
2020 -2.0 -0.06 9.40 18.22 -
2021 -2.3 0.04 2.75 882.83 -
2022 -1.4 -0.10 -7.87 77.80 -
2023 -1.0 0.01 2.33 0.00 -
2024 -0.5 0.01 1.09 0.00 -
2025 -0.6 0.01 1.31 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-321.60 $10.45M $-3.25M -31.1%
2017 $-278.40 $5.43M $-7.15M -131.6%
2018 $-162.09 $5.24M $-8.9M -169.8%
2019 $-115.88 $4.63M $-9.36M -202.1%
2020 $-154.45 $2.36M $-17.69M -749.9%
2021 $-75.06 $824.27K $-12.55M -1522.7%
2022 $-76.89 $948.91K $-13.8M -1454.1%
2023 $-12.66 $839.36K $-6.14M -731.6%
2024 $-5.23 $119.37K $-8.68M -7268.1%
2025 $-2.14 $0.00 $-11.08M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.85 $-0.85 – $-0.85 $800K $800K – $800K 1
2027 $-0.85 $-0.85 – $-0.85 $1M $1M – $1M 1
2028 $-0.78 $-0.78 – $-0.78 $2M $2M – $2M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message